Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Share-based Compensation: 2012-2024

Historic Share-based Compensation for Neurogene (NGNE) over the last 13 years, with Dec 2024 value amounting to $8.3 million.

  • Neurogene's Share-based Compensation rose 36.01% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.3 million, marking a year-over-year increase of 115.06%. This contributed to the annual value of $8.3 million for FY2024, which is 486.74% up from last year.
  • Per Neurogene's latest filing, its Share-based Compensation stood at $8.3 million for FY2024, which was up 486.74% from $1.4 million recorded in FY2023.
  • In the past 5 years, Neurogene's Share-based Compensation ranged from a high of $11.6 million in FY2021 and a low of $1.3 million during FY2022.
  • Its 3-year average for Share-based Compensation is $3.7 million, with a median of $1.4 million in 2023.
  • As far as peak fluctuations go, Neurogene's Share-based Compensation slumped by 89.17% in 2022, and later soared by 486.74% in 2024.
  • Yearly analysis of 5 years shows Neurogene's Share-based Compensation stood at $5.6 million in 2020, then spiked by 105.57% to $11.6 million in 2021, then slumped by 89.17% to $1.3 million in 2022, then rose by 13.26% to $1.4 million in 2023, then surged by 486.74% to $8.3 million in 2024.